VI. FDG‐PET as a biomarker in lymphoma: from qualitative to quantitative analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|33|S1|38-41

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.33, Iss.S1, 2015-06, pp. : 38-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FDG-PET worthwhile in head and neck cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 346, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Fundamentals of Quantitative PET Data Analysis

By  

Current Pharmaceutical Design, Vol. 8, Iss. 16, 2002-07 ,pp. : 1513-1526

Bentham Science Publishers

Access to resources Recommend Favorite

Nitroglycerin: Qualitative and quantitative analysis (A review)

By Grigor’eva V.   Efremenko O.   Kharitonov Yu.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 10, 2004-10 ,pp. : 562-568

Springer Publishing Company

Access to resources Recommend Favorite

Qualitative and Quantitative Analysis of Histone Acetylation by Mass Spectrometry

By  

Current Pharmaceutical Analysis, Vol. 1, Iss. 3, 2005-11 ,pp. : 319-327

Bentham Science Publishers

Access to resources Recommend Favorite

FDG‐PET/CT is a pivotal imaging modality to diagnose rare intravascular large B‐cell lymphoma: case report and review of literature

By  

Hematological Oncology (Electronic), Vol. 33, Iss. 2, 2015-06 ,pp. : 99-109

John Wiley & Sons Inc

Access to resources Recommend Favorite